Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.310
-0.040 (-2.96%)
Jan 30, 2025, 2:35 PM EST - Market open
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $32.43 million as of January 30, 2025. Its market cap has increased by 68.27% in one year.
Market Cap
32.43M
Enterprise Value
32.07M
1-Year Change
68.27%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $32.43M, a decrease of -88.87%. That is a compound annual growth rate of -20.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.84B |
| UnitedHealth Group | 499.24B |
| Novo Nordisk | 378.93B |
| Johnson & Johnson | 362.06B |
| AbbVie | 308.91B |
| Merck & Co. | 246.51B |
| Thermo Fisher Scientific | 223.49B |
| Abbott Laboratories | 220.95B |